YAYuji Aoki

Yuji Aoki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuji Aoki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Masato Aoki

    Matsumoto University, Matsumoto, Japan

    2 shared publications
  • Ayako Saito

    Department of Nutrition Management, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Japan

    1 shared publication
  • David Ja Jenkins

    Department of Nutritional Sciences University of Toronto M5S 3E2 Toronto ON Canada

    1 shared publication
  • Kazuya Yamada

    Matsumoto University, Matsumoto, Japan

    1 shared publication
  • Mika Shimizu

    Department of Pharmacy, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Japan

    1 shared publication
  • Nobuaki Watanabe

    Department of Neurosurgery, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Japan

    1 shared publication

Latest Publications

  • Open Access

    Seasonal variation in the prevalence of profound hyponatremia (<125 mmol/l) in patients on admission to an acute hospital in Japan

    by Nobukazu Sasaki, Yuji Aoki

    Hyponatremia is a common but important electrolyte disorder mostly complicated with other diseases. Recently, we experienced a case of a hypertensive patient in her seventies taking a thiazide diuretic, who presented with disorientation due to severe hyponatremia (serum sodium level, 104 mmol/l) on admission. Taking this opportunity, patients with profound hyponatremia (p = 0.002, χ2 test) higher than that in the cold season of November to March (1.8%, 32 in 1779 patients). The monthly prevalence tended to correlate with the monthly average temperature of the local area (r = 0.517, p = 0.085). There were six patients treated with thiazide diuretics in the warm season, while there were no such patients in the cold season, not reaching a significant difference (p = 0.240). The present study demonstrated an increased risk of hyponatremia in elderly patients during the warm season. Considering also the relevant literature, health professionals should pay enough attention to thiazide- or drug-induced hyponatremia and the impact of water/salt intake for heat exposure.


  • Open Access

    Nursing care using KT (Kuchi-kara Taberu) index radar chart enabling elderly patients with dysphagia to live like human beings after initiating gastrostomy feeding

    by Yumiko Aruga, Ayako Saito, Yuji Aoki

    Some patients with severe dysphagia need to undergo percutaneous endoscopic gastrostomy (gastrostomy feeding), which improves nutrition but leads them to feel they are not living like human beings. The KT (Kuchi-kara Taberu, or ingesting orally in Japanese) index was developed in order to comprehensively assess and intervene in problems with eating and swallowing. We present three cases where the KT index improved quality of life after gastrostomy feeding. Through continued nursing care using the KT index, the patient in Case 1 was able to eat orally again; the patient in Case 2 could eat a piece of jelly and communicate a little; and the patient in Case 3 was able to ingest a small amount of food orally, with support from her husband. Thus, the feeding support provided by the KT index radar chart improves quality of life, even after the implementation of gastrostomy feeding. Further studies are needed to investigate how the KT index best helps elderly patients with severe dysphagia live like human beings while taking into account the perspectives of patients and their family members.


  • Open Access

    Sodium-Glucose Co-Transporter 2 Inhibitors could Improve the Bioavailability of Vitamin C at the Kidney in Diabetes Treatment

    by Yuji Aoki, Masato Aoki, David Ja Jenkins

    It is known that plasma (serum) vitamin C level is lowered in diabetic patients by some mechanisms including renal loss [1]. Vitamin C and glucose filtered from the glomerulus are presumed to be reabsorbed at the renal proximal tubule by sodium-vitamin C co-transporter (SVCT) 1 and sodium-glucose co-transporter (SGLT) 2, respectively [2-4]. In the enterocyte that expresses SVCT 1 and SGLT 1, it was demonstrated in vitro that cellular uptake of vitamin C was inhibited by increasing concentrations of glucose in medium, which was not observed at the presence of phlorizin, a non-specific SGLT inhibitor [2]. If such an effect is applied to renal proximal tubular cells, it is hypothesized that SGLT 2 inhibitors can improve the bioavailability of vitamin C in diabetes treatment.


  • Open Access

    Leukocyte Telomere Length and Serum Levels of High-Molecular-Weight Adiponectin and Dehydroepiandrosterone-Sulfate Could Reflect Distinct Aspects of Longevity in Japanese Centenarians

    by Yuji Aoki, Masato Aoki, Kazuya Yamada

    Leukocyte telomere length and serum levels of high-molecular-weight adiponectin and dehydroepiandrosterone-sulfate (DHEA-S) were assessed in association with nutrition and performance status (PS) in Japanese centenarians. Twenty-three centenarians (five men, 18 women) were classified according to their PS 1 (nearly fully ambulatory, n = 2), 2 (in bed less than 50% of daytime, n = 10), 3 (in bed greater than 50%, n = 6), and 4 (completely bedridden, n = 5). Leukocyte telomere length was determined by the hybridization protection assay, and the adiponectin and DHEA-S levels were measured by chemiluminescent enzyme immunoassay. Among variables of PS, body mass index (BMI), albumin, adiponectin, DHEA-S, and telomere length, there were significant correlations between PS and albumin ( r = −.694, p < .01), between telomere length and BMI ( r = .522, p < .05), between adiponectin and BMI ( r = −.574, p < .01), and between DHEA-S and albumin ( r = .530, p < .01). When excluding two cancer-bearing centenarians with short telomere, telomere length significantly correlated with PS ( r = −.632, p < .01). It was indicated that the short leukocyte telomere was associated with poor PS and cancer development and that the adiponectin or DHEA-S was associated with adiposity or nutritional status. Despite a small number of subjects, these biomarkers seemed to reflect distinct aspects of longevity in Japanese centenarians.


  • Open Access

    Effects of Low-Dose Pioglitazone on Serum Levels of Adiponectin, Dehydroepiandrosterone, Amyloid Beta Peptide, and Lipid Profile in Elderly Japanese People with Type 2 Diabetes

    by Yuji Aoki

    This study was performed to see how pioglitazone at low doses could affect blood biomarkers related to atherosclerosis and aging. The effects of an add-on treatment with pioglitazone (15 mg for males and 7.5 mg for females) for 6 months were assessed in 24 outpatients (12 males, 12 females) with type 2 diabetes aged ≥ 70 years. As doses of sulfonylurea were reduced in 10 patients, no significant differences in HbA1c and glucose levels were seen. After the treatment, serum levels of HDL cholesterol, arachidonic acid (predominant in males), and high-molecular-weight adiponectin significantly increased. The level of dehydroepiandrosterone sulfate significantly decreased. No significant changes were seen in those of small dense LDL cholesterol, high-sensitivity C-reactive protein, and amyloid beta peptides 1–40 and 1–42. There was a slight but significant increase in body weight, but apparent adverse effects were not observed. In conclusion, pioglitazone at low doses increased serum adiponectin, HDL cholesterol, and arachidonic acid levels but decreased serum dehydroepiandrosterone level, not associated with glycemia, in elderly Japanese people with type 2 diabetes. An optimal dose of pioglitazone should be sought for to minimize its adverse effects and to fully exert its pleiotropic effects such as antiatherosclerotic and antiaging effects.

  • Open Access

    The Blood Glucose Level Increased in Parallel with the Heart Rate Following Cilostazol Administration in Three Diabetic Patients

    by Yuji Aoki, Mika Shimizu, Nobuaki Watanabe

    Cilostazol, a phosphodiesterase III inhibitor, is known to increase the heart rate; however, its effects on glucose metabolism remain unclear. We observed that the blood glucose level varied in parallel with the heart rate immediately after starting or stopping cilostazol therapy in three patients with type 2 diabetes. This finding indicates that cilostazol induces hyperglycemia and tachycardia in a portion of diabetic patients, presumably via similar pharmacological effects on different organs. Much more attention should be paid to the possible effects of cilostazol on glycemic control, including taking into consideration the risk-benefit ratio of cilostazol use and individual circumstances.